Abstract
The low efficiency of conventional therapies in achieving long-term survival of lung cancer patients calls for development of novel options. Aerosol gene delivery may provide the alternative for safe and effective treatment for lung cancer. Therefore, current study was performed to elucidate the potential effects of C-terminal modulator protein (CTMP) via aerosol on lung tumorigenesis. Lentiviral vector-CTMP was delivered into K-ras null lung cancer mice through the nose-only inhalation system for 30 min. After 48 h, the potential effects of CTMP on Akt1-related signals and cell cycle regulation in the lungs were evaluated by western blot, immunohistochemistry and zymography. Lentivirus-based CTMP delivery inhibited the Akt1 activity through selective suppression of Akt1 phosphorylation at Ser473. Aerosol delivery of CTMP inhibited proteins important for Akt1 signals, cell cycle and tumor metastasis in lungs of K-ras null mice. Together, our results suggest that lentivirus-mediated aerosol delivery of CTMP may be compatible with noninvasive in vivo gene therapy. Our results emphasize the importance of noninvasive-targeted delivery of CTMP for lung cancer therapy in the future. While the studies are conducted in mice, it is envisioned that noninvasive targeting the specific genes responsible for cancer progression is an attractive strategy for effective anticancer therapeutics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dailey LA, Kleemann E, Merdan T, Petersen H, Schmehl T, Gessler T et al. Modified polyethylenimines as non viral gene delivery systems for aerosol therapy: effects of nebulization on cellular uptake and transfection efficiency. J Control Release 2004; 100: 425–436.
Ferrari S, Geddes DM, Alton EW . Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv Drug Deliv Rev 2002; 54: 1373–1393.
Merdan T, Kopecek J, Kissel T . Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev 2002; 54: 715–758.
Gautam A, Densmore CL, Golunski E, Xu B, Waldrep JC . Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol Ther 2001; 3: 551–556.
Goula D, Becker N, Lemkine GF, Normandie P, Rodrigues J, Mantero S et al. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther 2000; 7: 499–504.
Philippe S, Sarkis C, Barkats M, Mammeri H, Ladroue C, Petit C et al. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc Natl Acad Sci USA 2006; 103: 17684–17689.
Sakhuja K, Reddy PS, Ganesh S, Cantaniag F, Pattison S, Limbach P et al. Optimization of the generation and propagation of gutless adenoviral vectors. Hum Gene Ther 2003; 14: 243–254.
Abordo-Adesida E, Follenzi A, Barcia C, Sciascia S, Castro MG, Naldini L et al. Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immuno response. Hum Gene Ther 2005; 16: 741–751.
Vivanco I, Sawyers CL . The phosphatidylinositol 3-kinase Akt pathway in human cancer. Nat Rev Cancer 2002; 2: 489–501.
Lawlor MA, Alessi DR . PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 2001; 114 (Part 16): 2903–2910.
Maira SM, Galetic I, Brazil DP, Kaech S, Ingley E, Thelen M et al. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science 2001; 294: 374–380.
Pellegata NS, Antoniono RJ, Redpathm JL, Stanbridge EJ . DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci USA 1996; 93: 15209–15214.
Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001; 410: 1111–1116.
Chetty C, Bhoopathi P, Joseph P, Chittivelu S, Rao JS, Lakka S . Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. Mol Cancer Ther 2006; 5: 2289–2299.
Plum SM, Holaday JW, Ruiz A, Madsen JW, Fogler WE, Fortier AH . Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development. Vaccine 2000; 19: 1294–1303.
Cherrington JM, Strawn LM, Shawver LK . New paradigms for the treatment of cancer: the role of anti-angiogenesis agents. Adv Cancer Res 2000; 79: 1–38.
Pusztaszeri MP, Seelentag W, Bosman FT . Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 2006; 54: 385–395.
Andreadis ST, Brott D, Fuller AO, Palsson BO . Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. J Virol 1997; 71: 7541–7548.
Le Doux JM, Davis HE, Morgan JR, Yarmush ML . Kinetics of retrovirus production and decay. Biotechnol Bioeng 1999; 63: 654–662.
Roe T, Reynolds TC, Yu G, Brown PO . Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12: 2099–2108.
Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263–267.
Breckpot K, Aerts JL, Thielemans K . Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics. Gene Ther 2007; 14: 847–862.
Tehrani AM, Hwang SK, Kim TH, Cho CS, Jin H, Nah WS et al. Aerosol delivery of Akt controls protein translation in the lungs of dual luciferase reporter mice. Gene Ther 2007; 14: 451–458.
West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003; 111: 81–90.
Brognard J, Clark AS, Ni Y, Dennis PA . Akt/protein kinase B is constitutively active in nonsmall cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001; 61: 3986–3997.
Gottlieb TM, Leal JF, Seger R, Taya Y, Oren M . Cross-talk between Akt, p53, and Mdm2: possible implications for the regulation of apoptosis. Oncogene 2002; 21: 1299–1303.
Lee HY, Suh YA, Kosmeder JW, Pezzuto JM, Hong WK, Kurie JM . Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells. Clin Cancer Res 2004; 10: 1074–1079.
Fukaya Y, Ishiguro N, Senga T, Ichigotani Y, Tsutsui M, Shioura T et al. A role for PI3K-Akt signaling in pulmonary metastatic nodule formation of the osteosarcoma cell line, LM8. Oncol Rep 2005; 14: 847–852.
Harada K, Supriatno, Kawashima Y, Yoshida H, Sato M . S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2. Int J Oncol 2007; 30: 365–374.
Straub AC, Stolz DB, Vin H, Ross MA, Soucy NV, Klei LR et al. Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling mice. Toxicol Appl Pharmacol 2007; 222: 327–336.
Chen ML, Xu PZ, Peng X, Chen WS, Guzman G, Yang X et al. The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/− mice. Genes Dev 2006; 20: 1569–1574.
Kim HW, Park IK, Cho CS, Lee KH, Beck Jr GR, Colburn NH et al. Aerosol delivery of glucosylated polyethyenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Cancer Res 2004; 64: 7971–7976.
Skeen JE, Bhaskar PT, Chen CC, Chen WS, Peng X, Nogueira V et al. Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORS1-dependent manner. Cancer Cell 2006; 10: 269–280.
Wyszomierski SL, Yu D . A knotty turnabout? Akt1 as a metastasis suppressor. Cancer Cell 2005; 8: 437–439.
Acknowledgements
This work was partially supported by the grants from the Korea Research Foundation (KRF-2006-311-E00507) in Korea. MHC and SHC were supported by the Nano Systems Institute-National Core Research Center (NSI-NCRC) program of KOSEF. SKH, JTK, SJP, ESL, YSC are also grateful for the award of the BK21 fellowship. KHL was supported by 21C Frontier Functional Human Genome Project (FG03-0601-003-1-0-0) and National Nuclear R&D Program from Ministry of Science and Technology. GRB Jr was supported by National Cancer Institute Grant CA84573.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hwang, SK., Kwon, JT., Park, SJ. et al. Lentivirus-mediated carboxyl-terminal modulator protein gene transfection via aerosol in lungs of K-ras null mice. Gene Ther 14, 1721–1730 (2007). https://doi.org/10.1038/sj.gt.3303042
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3303042
Keywords
This article is cited by
-
Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1
Journal of Molecular Medicine (2015)
-
Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice
Cancer Gene Therapy (2013)
-
Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras LA1 mice
Cellular Oncology (2013)
-
Heat shock protein 70-mediated sensitization of cells to apoptosis by Carboxyl-Terminal Modulator Protein
BMC Cell Biology (2009)